Document Detail

Acute stroke: techniques and results with the merci retriever.
MedLine Citation:
PMID:  22464302     Owner:  NLM     Status:  In-Data-Review    
Acute ischemic stroke is one of the most prominent causes of death and disability in the modern world. Despite extensive research, the only Food and Drug Administration-approved pharmacologic treatment is intravenous recombinant tissue plasminogen activator (rt-PA). Although reperfusion remains the most robust predictor of clinical outcome, rt-PA has been linked to low recanalization rates in large-vessel occlusion. Endovascular techniques have been developed over past decade with several theoretic advantages over intravenous rt-PA alone, including longer treatment windows and higher recanalization rates in large-vessel occlusions. The Merci retriever thrombectomy device was approved by the Food and Drug Administration in 2004 for removing thrombus in acute ischemic stroke. In this article, we review the indications for acute stroke endovascular treatment with the Merci retriever as well as the involved techniques and the results of research studies.
Ali Reza Noorian; Rishi Gupta; Raul G Nogueira
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Techniques in vascular and interventional radiology     Volume:  15     ISSN:  1557-9808     ISO Abbreviation:  Tech Vasc Interv Radiol     Publication Date:  2012 Mar 
Date Detail:
Created Date:  2012-04-02     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9806675     Medline TA:  Tech Vasc Interv Radiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  47-52     Citation Subset:  IM    
Copyright Information:
Copyright © 2012. Published by Elsevier Inc.
Department of Neurology, Emory University School of Medicine, Atlanta, GA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Intra-arterial Thrombolysis: Tissue Plasminogen Activator and Other Thrombolytic Agents.
Next Document:  Techniques and results-penumbra aspiration catheter.